Sri Lanka is grappling with a major dengue outbreak, recording 44,000 cases and 28 deaths this year, worsened by Cyclone Ditwah and unplanned urbanisation.
Scientists discovered OLE, a molecule that reprograms brain immune cells, potentially fighting Alzheimer's and improving memory.
Australia reports its first H5 bird flu case, marking the virus's spread to every continent and raising concerns for its unique native species.
Ebola cases in the Democratic Republic of Congo have climbed to 689, with 139 deaths, amid critical resource shortages.
Novel mRNA therapy combined with immune modulation shows preclinical potential to reprogram allergic responses and offer durable relief.
New research reveals women with Systemic Sclerosis face elevated pregnancy risks, hormone imbalances, and sexual dysfunction, urging integrated care.
UCLA-led research suggests subtle cardiac remodeling may predict higher risks of breast and colorectal cancers years before diagnosis.
Congo's Ebola outbreak has spread to Tchomia, a new health zone, with a significant rise in cases and deaths reported in Ituri.
Oxford researchers have launched human trials for the world's first AI-designed vaccine, targeting the deadly Crimean-Congo haemorrhagic fever.
Promising hantavirus vaccines and therapies show potential in clinical trials but face severe funding shortages to combat the deadly rodent-borne virus.
Dr. Karthick Sekar explains modern minimally invasive surgical solutions that offer faster recovery and minimal scarring for patients suffering from TMJ disorders.
WHO warns contact tracing lags at 45% as violence and travel bans hinder containment of the rare Bundibugyo Ebola strain in Congo.